Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Children International’s 2013 Youth Report is available beginning today, International Youth Day. The report explains how Children International’s youth programs, with community centers at the core, measurably change outcomes for impoverished youth. The majority of the world’s 1.7 billion young people ages 10 to 24 live in developing countries – many in extreme poverty where they routinely confront threats to their personal safety and progress. Without positive intervention like Children International’s successful youth programs, these at-risk youth can remain trapped in an intergenerational cycle of poverty.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/57997-children-international-2013-youth-report-results-now-available
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
workerly.com: the Social Network for Freelancers. worker.ly
is aimed at providing professionals with the easiest way to get in
touch with capable freelancers all over the world. As opposed to many
social networks, worker.ly does not focus on personal branding, but
only on results. How do we make it happen? Projects are made of real people. The
projects you have contributed to probably included more than one
person. The good news is: when adding projects to your portfolio, you
will be able to add a list of your coworkers. The better news is:
adding them will trigger a verification system allowing them to rate
your work, confirm that yes, you are a real person and yes, so are
they. The long term effect? A network exclusively made of real people!
Wilson Golf, the Chicago-based company with more Major victories (61) than any other golf club manufacturer, today announced strong 2010 sales results during a press conference at the 2011 PGA Merchandise Show. Wilson Golf has experienced a tremendous sales turnaround in 2010, posting a 10 percent increase in sales worldwide over 2009 and a 23 percent increase in the U.S. alone.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/wilson/48191/
Most people are deficient in vitamin D3. You can supplement with 2000, 5000, or 10,000 IU of vitamin D3 but that may not be enough. The only way to tell if your blood has an adequate amount of D3 is to have a blood test for D3 and have your doctor examine the results.
GoGo squeeZ applesauce on-the-go, the leader in fruit-based pouches, announced today the results of a nationwide survey they commissioned to discover the state of playfulness in the USA, which revealed that U.S. families have trouble incorporating playfulness into their daily lives. GoGo squeeZ realizes that being playful is an important aspect of childhood development and is committed to providing parents with the tools they need to empower playfulness, not just in their children but also in themselves.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61992-gogo-squeez-teams-celeb-dad-jerry-o-connell
Third Box, a new resource for the unsure women in an unintended pregnancy, today announced results of a recent survey demonstrating that despite the current polarizing two-box political approaches, one in four women in unintended pregnancies are unsure of what to do. This data corresponds with the organization’s expansion of its reach to women in California regions, and its footprint across the country providing free medical and emotional care, in a space apart from ideology or politics, with no bias toward outcome.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7339251-third-box-sponsored-study-women-in-unintended-pregnancies-uncertain-national-expansion-campaign/
www.Clicktecs.com The digital world has permeated every aspect of our daily lives, from the way we spend our time, to the way we spend our money. It has changed the way we communicate, and it has really changed the way we seek and receive information.
Businesses are recognizing this shift from offline media to online media, and realizing that in order to acquire leads, build targeted traffic and convert more customers in the new normal, they have to start measuring different metrics.
Some companies have started testing SEO, and others may be doing some Social Media. If you are publishing content, then you may unknowingly be doing content marketing. These three commonly used marketing tactics, when executed together on a consistent basis can produce some really great results and it is what smart marketers have figured out. Conveniently named \'Optimized Content Marketing\'.
A beautiful young Caucasian sports groupies wildest dreams come true when she falls for a married African American pro-basketball star. But the fantasy soon ends when her affair with the athlete results in an extraordinary court battle for custody of their mixed-race son. Staring Jennifer Finnigan and Doug Savant. Premieres Sunday January 18th at 8pm ET on Lifetime Movie Network.
